secwatch.observer — SEC 8-K summary
======================================

Issuer:     HENRY SCHEIN INC (HSIC)
CIK:        0001000228
Form:       8-K
Filed at:   2025-08-05T23:59:59+00:00
Accession:  0001000228-25-000042
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Henry Schein Q2 GAAP EPS $0.70 (down 12.5% YoY); maintains FY25 guidance
------------------------------------------------------------------------

- Q2 GAAP net income $86M ($0.70 diluted EPS) vs $104M ($0.80) YoY; non-GAAP EPS $1.10 vs $1.23.
- Total sales $3.2B, up 3.3% as-reported; internal growth 1.9%; Global Medical Distribution up 6.1%.
- Adjusted EBITDA $256M vs $268M; recorded $23M restructuring costs targeting $100M+ annual run-rate savings.
- FY25 guidance maintained: non-GAAP diluted EPS $4.80-$4.94, sales growth 2%-4%, mid-single digit Adj. EBITDA growth.
- Repurchased ~3.7M shares for $259M in Q2; $432M remaining for future repurchases.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000228/000100022825000042/0001000228-25-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000228/000100022825000042/hsic-20250805.htm
  HTML page:      https://secwatch.observer/filing/0001000228-25-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer